Tejnaksh Healthcare Limited Q2 profit rises to Rs 63.85 lakh

Tejnaksh Healthcare Limited reported consolidated profit of Rs 63.85 lakh for the quarter ended September 30, 2026, up from Rs 6.07 lakh in the preceding quarter, as total income rose to Rs 3.24 crore from Rs 2.75 crore. Profit was also above the Rs 33.15 lakh reported in the September 2025 quarter.

How did Tejnaksh Healthcare perform in the September 2026 quarter?

Tejnaksh Healthcare increased consolidated profit to Rs 63.85 lakh in the quarter ended September 30, 2026, from Rs 6.07 lakh in the quarter ended June 30, 2026 and Rs 33.15 lakh a year earlier. Profit before tax was Rs 74.88 lakh, compared with Rs 42.06 lakh sequentially and Rs 48.53 lakh in the September 2025 quarter.

Revenue from operations rose to Rs 3.15 crore in the September 2026 quarter, from Rs 2.65 crore in June 2026 and Rs 2.98 crore a year earlier. Other income was Rs 9.20 lakh, below Rs 9.74 lakh in the June quarter and Rs 9.23 lakh in the year-earlier period, leaving total income at Rs 3.24 crore.

The increase in total income was Rs 49.14 lakh from the June quarter, while total expenses increased by Rs 16.32 lakh to Rs 2.49 crore. This reported difference coincided with a Rs 32.82 lakh increase in profit before tax. Total comprehensive income was Rs 64.49 lakh, including Rs 57.53 lakh attributable to equity holders and Rs 6.96 lakh attributable to non-controlling interests.

What changed in Tejnaksh Healthcare’s quarterly cost base?

Tejnaksh Healthcare’s largest disclosed quarterly cost was other expenses at Rs 1.59 crore, up from Rs 1.43 crore in June 2026 and Rs 1.51 crore in September 2025. Employee benefits expense fell to Rs 24.80 lakh from Rs 29.06 lakh sequentially and from Rs 41.35 lakh a year earlier, while depreciation and amortisation was broadly unchanged at Rs 35.48 lakh against Rs 35.45 lakh in June.

Finance costs were Rs 25,000 in the September quarter, compared with Rs 1.19 lakh in the preceding quarter and Rs 3.26 lakh a year earlier. Purchases of stock-in-trade were Rs 30.09 lakh, versus Rs 29.51 lakh in June 2026, while changes in inventories produced a Rs 1.11 lakh reduction in expenses after a Rs 4.96 lakh increase in the prior quarter.

Tax expense reduced the Rs 74.88 lakh pre-tax result to Rs 63.85 lakh of profit. Current tax was Rs 11.56 lakh, compared with Rs 11.82 lakh in June, and deferred tax was a Rs 53,000 credit after a Rs 4.17 lakh deferred-tax expense in the preceding quarter. The filing did not provide a separate operational explanation for the movement in profit.

What do Tejnaksh Healthcare’s half-year results show?

Tejnaksh Healthcare reported consolidated profit of Rs 69.92 lakh for the six months ended September 30, 2026, compared with Rs 54.42 lakh in the corresponding prior-year half. Total income rose to Rs 5.99 crore from Rs 5.80 crore, while revenue from operations increased to Rs 5.80 crore from Rs 5.62 crore.

Profit before tax reached Rs 1.17 crore in the first half, compared with Rs 77.03 lakh in the comparable 2025 period. Total expenses declined to Rs 4.82 crore from Rs 5.03 crore, despite the increase in income. Employee benefits expense decreased to Rs 53.86 lakh from Rs 74.81 lakh, whereas other expenses rose to Rs 3.01 crore from Rs 2.05 crore.

Depreciation and amortisation for the six months was Rs 70.93 lakh, close to Rs 70.51 lakh a year earlier. Finance costs fell to Rs 1.44 lakh from Rs 8.60 lakh, and current tax increased to Rs 23.38 lakh from Rs 16.07 lakh. Profit attributable to equity holders was Rs 83.98 lakh, while non-controlling interests recorded a Rs 5.94 lakh loss for the half year.

What does Tejnaksh Healthcare’s balance sheet and cash flow indicate?

Tejnaksh Healthcare had consolidated total assets of Rs 31.30 crore at September 30, 2026, compared with Rs 30.05 crore at the previous financial-year end. Total equity was Rs 28.55 crore, including Rs 27.99 crore attributable to owners and Rs 55.37 lakh of non-controlling interest. The balance sheet reported no current or non-current borrowings at either date.

Non-current liabilities were Rs 1.76 crore at September 30, 2026, against Rs 1.78 crore at the prior year-end, while current liabilities rose to Rs 99.43 lakh from Rs 62.78 lakh. Property, plant and equipment declined to Rs 17.89 crore from Rs 18.29 crore, and other financial assets increased to Rs 3.78 crore from Rs 2.23 crore.

Net cash generated from operating activities was Rs 10.56 lakh for the six months ended September 30, 2026, down from Rs 1.72 crore in the prior-year half. Cash generated from operations before income taxes was Rs 34.08 lakh, compared with Rs 2.55 crore a year earlier. The cash-flow statement recorded a Rs 1.56 crore increase in other financial assets and Rs 23.52 lakh of net income taxes paid during the current half.

How were Tejnaksh Healthcare’s September-quarter figures reviewed?

Tejnaksh Healthcare’s Board approved the unaudited consolidated interim results on November 12, 2026, after they were reviewed and recommended by the Audit Committee. The statutory auditors conducted a limited review and issued an unmodified conclusion, stating that nothing had come to their attention to suggest a material misstatement.

The September-quarter figures are balancing figures derived from the unaudited six-month results ended September 30, 2026 and the previously published June-quarter results. The consolidated results include subsidiary Tejvedaant Healthcare Private Limited, and the group reported one business segment, medical and healthcare services, operating primarily in India.

Conclusion

Tejnaksh Healthcare’s September 2026 quarter paired higher operating revenue with a smaller increase in expenses, resulting in consolidated profit of Rs 63.85 lakh. The first-half comparison also showed a rise in profit before tax to Rs 1.17 crore, while total expenses declined from the prior-year period.

The next result will indicate whether quarterly revenue from operations of Rs 3.15 crore and employee benefits expense of Rs 24.80 lakh are sustained. Investors can also watch operating cash generation and the balance in other financial assets, which increased to Rs 3.78 crore while first-half operating cash flow was Rs 10.56 lakh.